Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Clinical trial NCT03030183 · COMPLETED

Trial details

NCT number: NCT03030183
Sponsor: Ra Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Start date: 2017-04-17
Primary completion: 2018-03-28
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.